The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients

American Journal of Surgical Pathology

Volumn 32, Issue 7, 2008, Pages 1106-1107

  Murali, Rajmohan ^a,b,c   Thompson, John F ^b,d   Shaw, Helen M ^b,d   Scolyer, Richard A ^a,b,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b MELANOMA INSTITUTE AUSTRALIA   (Australia)

^c University of Sydney   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CELL ISOLATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MICROMETASTASIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; CHEMISTRY; DISEASE FREE SURVIVAL; FOLLOW UP; LYMPH NODE; METASTASIS; NOTE; PATHOLOGY; SKIN TUMOR; SURVIVAL RATE; TIME;

MART1 ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ANTIGENS, NEOPLASM; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM PROTEINS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 47249145646     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318162442e     Document Type: Letter

References (13)

1. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648.
2. Cochran AJ, Wen DR, Huang RR, et al. Prediction of metastatic melanoma in non-sentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol. 2004;17:747-755.
3. Dewar DJ, Newell B, Green MA, et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol. 2004;22:3345-3349.
4. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16:2253-2260.
5. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol. 2003;27: 1197-1202.
6. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-1317.
7. Satzger I, Volker B, Meier A, et al. Prognostic significance of isolated HMB45 or Melan a positive cells in melanoma sentinel lymph nodes. Am J Surg Pathol. 2007;31:1175-1180.
8. Scheri RP, Essner R, Turner RR, et al. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol. 2007;14:2861-2866.
9. Schmid-Wendtner MH, Baumert J, Schmidt M, et al. Late metastases of cutaneous melanoma: an analysis of 31 patients. J Am Acad Dermatol. 2000;43:605-609.
10. Scolyer RA, Li LX, McCarthy SW, et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol. 2004;122:532-539.
11. Scolyer RA, Murali R, Gershenwald JE, et al. Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell. Ann Oncol. 2007;18:806-808.
12. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001; 91:2110-2121.
13. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metas-tases in sentinel lymph nodes. Cancer. 1999; 86:617-627.